[Functional characterization of SLC12A1 gene variants in 3 patients with Bartter syndrome type Ⅰ].

The 3 SLC12A1 variants cause expression or subcellular localization defects of the protein. The findings that plasma membrane expression and activity can be rescued by 4PBA might help to develop novel therapeutic strategy for Bartter syndrome type Ⅰ.